Inactive Instrument

McKesson Europe AG

CLS1

DE000CLS1001

Celesio AG Reaffirms Earnings Guidance for the Full Year 2012

October 25, 2012 at 03:44 pm

Celesio AG has confirmed its expectations for the 2012 fiscal year and assumes that adjusted EBITDA for 2012 will at least match the 2011 level with a minimum of €550 million.

Latest news about McKesson Europe AG

PHOENIX Pharmahandel GmbH & Co KG completed the acquisition of Certain European Businesses of McKesson Europe AG.	30/10/22	CI
Erhvervsinvest Management A/S acquired Tjellesen Max Jenne A/S from McKesson Europe AG.	30/06/22	CI
McKesson Europe AG Reports Earnings Results for the Full Year Ended March 31, 2022	20/06/22	CI
Opioid distributors reach $518 million settlement with washington state - mckesson	03/05/22	RE
AURELIUS Equity Opportunities SE & Co. KGaA acquired Admenta UK Limited.	12/04/22	CI
Global markets live: JP Morgan, Boeing, Adobe, eBay, Amazon...	18/06/21
Corporation of European Pharmaceutical Distributors N.V. intends to acquire Admenta Sweden AB from McKesson Europe AG.	11/04/21	CI
Mckesson Europe Ag Reports Earnings Results for the Full Year Ended March 31, 2020	11/02/21	CI
Mckesson Europe Ag Reports Earnings Results for the Full Year Ended March 31, 2019	19/07/19	CI
Celesio Announces Earnings Results for the Fiscal Year 2017; Provides Consolidated Earnings Guidance for the Fiscal Year 2018	22/06/17	CI
McKesson Europe AG(XTRA:CLS1) dropped from S&P Global BMI Index	02/05/17	CI
Celesio AG (DB:CLS1) completed the acquisition of Belmedis SA, Cophana SA, Alphar Partners SA, Espafarmed SLU and 54.26% stake in Sofiadis NV from Groupe Welcoop SA.	01/05/17	CI
Celesio Group Reports Consolidated Earnings Results for the First Half Ended September 30, 2016, Provides Earnings Guidance for the Fiscal Year 2016	21/11/16	CI
Celesio AG(XTRA:CLS1) added to S&P Global BMI Index	19/09/16	CI
Celesio Seeks To Sell Pharmacies	29/07/16	CI
Celesio Announces Group Earnings Results for Fiscal 2016; Provides Earnings Guidance for Fiscal 2017	23/06/16	CI
SC Participações Empresariais completed the acquisition of Panpharma Participacoes S.A. and Onco Prod Distribuidora de Produtos Hospitalares e Oncológicos S.A. from Celesio AG (DB:CLS1).	30/05/16	CI
Celesio AG (DB:CLS1) completed the acquisition of Holon Group.	30/05/16	CI
Celesio May Takeover PCB	25/05/16	CI
Celesio Intends To Acquire Sainsbury's Pharmacy Stores	29/04/16	CI
Celesio May Have To Sell Pharmacies In 13 Areas	29/04/16	CI
Celesio AG (DB:CLS1) entered into an agreement to acquire Holon Group.	10/04/16	CI
Celesio AG (DB:CLS1) completed the acquisition of certain supply chain business assets and MASTA business division assets from UDG Healthcare plc, United Drug Distributors, Dublin Drug Company Limited, Alchem Plc and United Drug (UK) Holdings Limited.	31/03/16	CI
SC Participações Empresariais signed an agreement to acquire Panpharma Participacoes S.A. and Onco Prod Distribuidora de Produtos Hospitalares e Oncológicos S.A. from Celesio AG (DB:CLS1).	31/01/16	CI
Celesio AG Reports Earnings Results for the Nine Months Ended December 31, 2015	28/01/16	CI

McKesson Europe AG, formerly known as Celesio AG, is a Germany-based wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sector. The Company operates through two segments: Consumer Solutions and Pharmacy Solutions. The Consumer Solutions segment focuses on patients and consumers and is comprised of the pharmacy business. The Pharmacy Solutions segment serves pharmacies and hospitals and is primarily concerned with the Company's wholesale activities. It also provides related services, such as training and consulting services, as well as organizational and communication skills workshops. The Company operates in Germany, the Netherlands, Belgium, France, Austria, Slovenia, Italy, Portugal, the United Kingdom, Ireland, Denmark, Norway and Sweden.

Sector

Pharmaceuticals

More about the company

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CARDINAL HEALTH, INC.	-2.46%	23.95B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+14.23%	8.7B
SINOPHARM GROUP CO. LTD.	+1.47%	8.29B
HUADONG MEDICINE CO., LTD	-32.92%	6.7B
H. LUNDBECK A/S	+18.62%	5.38B
GALENICA AG	+1.10%	4.08B
EBOS GROUP LIMITED	-9.24%	3.79B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-10.20%	3.3B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+7.58%	3.2B

Pharmaceuticals Wholesale